Gross Margin
34.05%vs Specialty Chemicals peers Updated Sep 20, 2026Profit Margin
11.89%vs Specialty Chemicals peers Updated Sep 20, 2026Operating Margin
14.61%vs Specialty Chemicals peers Updated Sep 20, 2026Return on Assets (TTM)
1.59%vs Specialty Chemicals peers Updated Sep 20, 2026Return on Equity (TTM)
6.13%vs Specialty Chemicals peers Updated Sep 20, 2026Revenue (TTM)
129.32BKRW93.34M · vs all stocks (USD) Updated Sep 20, 2026Revenue per Share (TTM)
10.78KKRWUpdated Sep 20, 2026Quarterly Revenue Growth
24.50%vs Specialty Chemicals peers Updated Sep 20, 2026Gross Profit (TTM)
43.16BKRW31.16M · vs all stocks (USD) Updated Sep 20, 2026EBITDA (TTM)
40.59BKRW29.30M · vs all stocks (USD) Updated Sep 20, 2026Net Income (TTM)
15.38BKRW11.10M · vs all stocks (USD) Updated Sep 20, 2026Quarterly Earnings Growth (YoY)
24.48%vs Specialty Chemicals peers Updated Sep 20, 2026Operating Cash Flow (TTM)
27.90BKRW20.14M · vs all stocks (USD) Updated Sep 20, 2026Levered Free Cash Flow (TTM)
-19.80BKRW-14.29M · vs all stocks (USD) Updated Sep 20, 2026Trailing Annual Dividend Rate
250.00KRWUpdated Sep 20, 2026Trailing Annual Dividend Yield
0.47%Updated Sep 20, 20265-Year Average Dividend Yield
0.29%Updated Sep 20, 2026Payout Ratio
19.56%vs Specialty Chemicals peers Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 183.82%.Updated Sep 20, 2026Revenue
111.75BKRWFY2025 · Dec 31, 2025Cost of Goods Sold
73.69BKRWFY2025 · Dec 31, 2025Gross Profit
38.06BKRWFY2025 · Dec 31, 2025Operating Income
4.68BKRW3.38M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
2.30BKRWFY2025 · Dec 31, 2025Income Tax Expense
663.21MKRWFY2025 · Dec 31, 2025Net Income
1.63BKRWFY2025 · Dec 31, 2025EBIT
12.89BKRWFY2025 · Dec 31, 2025EBITDA (Income Statement)
23.38BKRWFY2025 · Dec 31, 2025Research & Development
8.61BKRWFY2025 · Dec 31, 2025Selling, General & Administrative
9.38BKRWFY2025 · Dec 31, 2025Other Operating Expenses
761.27MKRWFY2025 · Dec 31, 2025Non-operating Interest Income
6.88BKRWFY2025 · Dec 31, 2025Non-operating Interest Expense
10.60BKRWFY2025 · Dec 31, 2025Net Income from Continuing Operations
1.63BKRWFY2025 · Dec 31, 2025Operating Cash Flow
-4.65BKRWFY2025 · Dec 31, 2025Free Cash Flow
-16.07BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
55.33BKRWFY2025 · Dec 31, 2025Starting Profit (CF Statement)
1.63BKRWFY2025 · Dec 31, 2025Stock-based Compensation
1.91BKRWFY2025 · Dec 31, 2025Other Non-cash Items
3.96BKRWFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-2.61BKRWFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-9.54BKRWFY2025 · Dec 31, 2025Capital Expenditures
-11.42BKRWFY2025 · Dec 31, 2025Net Intangibles (CF)
-557.21MKRWFY2025 · Dec 31, 2025Purchase of Investments
-641.77BKRWFY2025 · Dec 31, 2025Sale of Investments
649.13BKRWFY2025 · Dec 31, 2025Other Investing Activity
-9.69MKRWFY2025 · Dec 31, 2025Net Investing Cash Flow
-4.07BKRWFY2025 · Dec 31, 2025Long-term Debt Issuance
6.84BKRWFY2025 · Dec 31, 2025Long-term Debt Payments
-6.84BKRWFY2025 · Dec 31, 2025Common Dividends Paid
-2.99BKRWFY2025 · Dec 31, 2025Other Financing Charges
-825.40KKRWFY2025 · Dec 31, 2025Net Financing Cash Flow
-2.96BKRWFY2025 · Dec 31, 2025